CROSS COUNTRY HEALTHCARE INC (CCRN) Forecast, Price Target & Analyst Ratings

NASDAQ:CCRN • US2274831047

Current stock price

9.86 USD
-0.03 (-0.3%)
At close:
9.86 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CROSS COUNTRY HEALTHCARE INC (CCRN).

Forecast Snapshot

Consensus Price Target

Price Target
$11.90
+ 20.69% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.04
Revenue Estimate
241.58M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
74.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.90
Upside
+ 20.69%
From current price of $9.86 to mean target of $11.90, Based on 15 analyst forecasts
Low
$10.10
Median
$10.71
High
$15.75

Price Target Revisions

1 Month
2.55%
3 Months
1.87%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for CCRN. The average price target is 11.9 USD. This implies a price increase of 20.69% is expected in the next year compared to the current price of 9.86.
The average price target has been revised upward by 1.87% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CCRN Current Analyst RatingCCRN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

CCRN Historical Analyst RatingsCCRN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
74.67%
CCRN was analyzed by 15 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about CCRN.
In the previous month the buy percentage consensus was at a similar level.
CCRN was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-19WedbushUpgrade Neutral -> Outperform
2026-03-05BenchmarkUpgrade Hold -> Buy
2026-02-03WedbushInitiate Neutral
2025-12-09UBSMaintains Neutral -> Neutral
2025-06-17Barrington ResearchMaintains Market Perform -> Market Perform
2025-05-13UBSMaintains Neutral -> Neutral
2025-03-14Barrington ResearchMaintains Market Perform -> Market Perform
2025-02-06JMP SecuritiesReiterate Market Perform -> Market Perform
2024-12-10Barrington ResearchDowngrade Outperform -> Market Perform
2024-12-05Truist SecuritiesMaintains Hold -> Hold
2024-11-07BenchmarkMaintains Buy -> Buy
2024-10-21Truist SecuritiesMaintains Hold -> Hold
2024-08-08Barrington ResearchMaintains Outperform -> Outperform
2024-08-01Truist SecuritiesMaintains Hold -> Hold
2024-05-06Barrington ResearchMaintains Outperform -> Outperform
2024-05-02BenchmarkMaintains Buy -> Buy
2024-02-27Barrington ResearchMaintains Outperform -> Outperform
2024-02-22BenchmarkMaintains Buy -> Buy
2024-02-22Truist SecuritiesMaintains Hold -> Hold
2023-12-06JMP SecuritiesInitiate Market Perform
2023-11-30UBSInitiate Neutral
2023-11-29Barrington ResearchMaintains Outperform -> Outperform
2023-11-03Truist SecuritiesMaintains Hold -> Hold
2023-11-03JefferiesDowngrade Buy -> Hold
2023-10-05JefferiesMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
-$0.04
Revenue Estimate
241.58M
Revenue Q2Q
-17.66%
EPS Q2Q
-173.66%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
-0.30%
Revenue (3 Months)
-7.76%
EPS (1 Month)
-23.80%
EPS (3 Months)
-388.87%

Next Earnings Summary

CCRN is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is -0.04 USD and the consensus revenue estimate is 241.58M USD.
The next earnings revenue estimate has been revised downward by 7.76% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
CCRN revenue by date.CCRN revenue by date.
2.02B
-28.04%		1.344B
-33.46%		1.054B
-21.56%		996.07M
-5.52%		1.046B
5.01%		1.099B
5.07%
EBITDA
YoY % growth
CCRN ebitda by date.CCRN ebitda by date.
135.516M
-53.89%		19.443M
-85.65%		19.332M
-0.57%		27.927M
44.46%		35.37M
26.65%		52.632M
48.80%
EBIT
YoY % growth
CCRN ebit by date.CCRN ebit by date.
117.169M
-58.35%		1.243M
-98.94%		2.538M
104.18%		3.935M
55.04%		10.574M
168.72%		15.3M
44.69%
Operating Margin
CCRN operating margin by date.CCRN operating margin by date.
5.80%0.09%0.24%0.40%1.01%1.39%
EPS
YoY % growth
CCRN eps by date.CCRN eps by date.
2.21
-57.98%		0.45
-79.64%		0.02
-95.56%		0.11
455.34%		0.28
148.98%		0.42
51.23%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.04
-173.66%		0.02
349.29%		0.05
81.32%		0.09
249.23%		0.01
127.69%		0.04
80.03%		0.08
38.76%		0.10
9.36%
Revenue
Q2Q % growth		241.58M
-17.66%		245.66M
-10.37%		252.9M
1.14%		255.91M
8.09%		253.88M
5.09%		256.05M
4.23%		264.45M
4.57%		267.76M
4.63%
EBITDA
Q2Q % growth		4.489M
-26.85%		6.153M
-42.47%		7.798M
-43.36%		9.606M
-37.37%		6.572M
46.40%		7.707M
25.26%		8.926M
14.47%		10.13M
5.45%
EBIT
Q2Q % growth		-1.826M
-233.77%		152.745K
-91.62%		1.672M
107.44%		3.44M
336.26%		2.571M
240.81%		3.388M
2,118.08%		4.624M
176.56%		5.438M
58.08%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CCRN Yearly Revenue VS EstimatesCCRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
CCRN Yearly EPS VS EstimatesCCRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
175.50%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
0.18%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
80.75%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CROSS COUNTRY HEALTHCARE INC / CCRN Forecast FAQ

What is the average price target for CROSS COUNTRY HEALTHCARE INC (CCRN) stock?

15 analysts have analysed CCRN and the average price target is 11.9 USD. This implies a price increase of 20.69% is expected in the next year compared to the current price of 9.86.

What is the next earnings date for CCRN stock?

CROSS COUNTRY HEALTHCARE INC (CCRN) will report earnings on 2026-05-05, after the market close.

What are the consensus estimates for CCRN stock next earnings?

The consensus EPS estimate for the next earnings of CROSS COUNTRY HEALTHCARE INC (CCRN) is -0.04 USD and the consensus revenue estimate is 241.58M USD.

What is the expected long term growth rate for CROSS COUNTRY HEALTHCARE INC (CCRN)?

The expected long term growth rate for CROSS COUNTRY HEALTHCARE INC (CCRN) is 0.18%.